ENVALITH
日本パーカライジング株式会社 logo

Nihon Parkerizing Co., Ltd.

4095Prime MarketChemicals

日本パーカライジング株式会社 logo
Nihon Parkerizing Co., Ltd.4095
Reference Indicators

Market Cap

2,212¥100M

P/E (Forecast)

11.9x

P/B

0.9x

Dividend Yield (Forecast)

3.00%

ROE

6.5%

EV/EBITDA

6.7x
Financial Summary
Unit: ¥M
Item
2022Mar 2022
2023Mar 2023
2024Mar 2024
2025Mar 2025
2026Mar 2026
Net Sales
117,752119,177125,085132,281138,155
Cost of Sales
79,33480,21582,39188,37292,043
Gross Profit
38,41838,96242,69343,90946,111
SG&A Expenses
25,04726,29327,43528,91031,297
Operating Income
13,37012,66815,25814,99814,814
Non-operating Income
4,2424,6855,5275,6905,689
Non-operating Expenses
610728839753835
Ordinary Income
17,00316,62519,94519,93619,667
Extraordinary Income
2879451,5011,1864,791
Extraordinary Losses
1,4459425111,4201,508
Pre-tax Income
15,84516,62820,93519,70222,951
Income Taxes
4,4034,4655,4075,5148,659
Net Income
9,0469,97313,19413,11212,940
EBITDA
19,33418,65721,53521,63322,032
Gross Margin
32.6%32.7%34.1%33.2%33.4%
Operating Margin
11.4%10.6%12.2%11.3%10.7%
ROA
4.0%4.2%4.9%4.9%4.7%
ROE
5.8%6.1%7.5%6.9%6.5%
Segment Performance
Unit: ¥M
2026
SegmentNet SalesOperating IncomeOperating Margin
薬品事業58,9199,36315.9%
装置事業27,6212,1167.7%
加工事業48,5704,6759.6%
その他3,043-19-0.6%